SCHEMBL7424079

SCHEMBL7424079

c1ccc2c(c1)CC(C1CCCCC1)O2

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.54
CHRM4 P08173 2/20 0.54
CHRM5 P08912 2/20 0.54
CHRM1 P11229 2/20 0.54
CHRM3 P20309 2/20 0.54
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
STS P08842 2/20 0.40
SIGMAR1 Q99720 1/20 0.37
PRCP P42785 1/20 0.37
AOC2 O75106 5/20 0.36
MAOA P21397 5/20 0.36
MAOB P27338 5/20 0.36
HTR2A P28223 3/20 0.36
HTR2C P28335 3/20 0.36
HTR2B P41595 3/20 0.36
HRH3 Q9Y5N1 2/20 0.36
DAO P14920 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17891950 0.90 CHRM2 (0.58) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL1579371 0.85 CHRM2 (0.50) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL8927167 0.82 CHRM2 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL12209509 0.82 CHRM2 (0.51) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL14849789 0.82 CHRM2 (0.48) CHRM2CHRM4CHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL2595440 0.81 CHRM2 (0.50) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL13850949 0.78 CHRM2 (0.48) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL1451005 0.78 STS (0.47) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL11452501 0.77 SMN1; SMN2 (0.53) TSHRSTSSIGMAR1MAOAMAOB
SCHEMBL15256106 0.77 SMN1; SMN2 (0.53) TSHRSTSSIGMAR1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5506247-A Compounds that inhibit complement and/or suppress immune activity T CELL SCIENCES, INC. (US) 1996-04-09 US claimed
US-5401767-A Compounds which inhibit complement and/or suppress immune activity T CELL SCIENCES, INC. (US) 1995-03-28 US claimed
EP-0561989-A4 1994-03-09 EP claimed
EP-0561989-A1 COMPOUNDS THAT INHIBIT COMPLEMENT AND/OR SUPPRESS IMMUNE ACTIVITY T CELL SCIENCES, INC. (US) 1993-09-29 EP claimed
WO-1992010096-A1 COMPOUNDS THAT INHIBIT COMPLEMENT AND/OR SUPPRESS IMMUNE ACTIVITY T CELL SCIENCES, INC. (US) 1992-06-25 WO claimed
US-8440706-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-14 US disclosed
US-6080782-A Cyclohexyl dihydrobenzofuranes BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2000-06-27 US disclosed
EP-0828727-A1 CYCLOHEXYL DIHYDROBENZOFURANES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1998-03-18 EP disclosed
US-5656659-A SUBSTITUTED DIHYDROBENZOFURAN COMPOUNDS T CELL SCIENCES, INC. (US) 1997-08-12 US disclosed
WO-1996036626-A1 CYCLOHEXYL DIHYDROBENZOFURANES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1996-11-21 WO disclosed
US-5366986-A SPIROBENZOFURAN-2(3H)-CYCLOALKANE COMPOUNDS T CELL SCIENCES, INC. (US) 1994-11-22 US disclosed
EP-0560929-A4 1994-08-31 EP disclosed
EP-0561989-A4 1994-03-09 EP disclosed
EP-0561989-A1 COMPOUNDS THAT INHIBIT COMPLEMENT AND/OR SUPPRESS IMMUNE ACTIVITY T CELL SCIENCES, INC. (US) 1993-09-29 EP disclosed
EP-0560929-A1 SYNERGISTIC COMPOSITIONS OF SOLUBLE COMPLEMENT RECEPTORS AND COMPOUNDS THAT INHIBIT COMPLEMENT AND/OR SUPPRESS IMMUNE ACTIVITY T CELL SCIENCES, INC. (US) 1993-09-22 EP disclosed
WO-1992010205-A1 SYNERGISTIC COMPOSITIONS OF SOLUBLE COMPLEMENT RECEPTORS AND COMPOUNDS THAT INHIBIT COMPLEMENT AND/OR SUPPRESS IMMUNE ACTIVITY T CELL SCIENCES, INC. (US) 1992-06-25 WO disclosed
US-4703052-A Hypoglycemic thiazolidinediones PFIZER INC. (US) 1987-10-27 US disclosed
EP-0207605-A1 Hypoglycemic thiazolidinediones PFIZER INC. (US) 1987-01-07 EP disclosed
WO-1986007056-A1 HYPOGLYCEMIC THIAZOLIDINEDIONES PFIZER INC. (US) 1986-12-04 WO disclosed